Global organ transplant immunosuppressant market 2017-2021

臓器移植用免疫抑制薬の世界市場2017-2021

◆タイトル:Global organ transplant immunosuppressant market 2017-2021
◆商品コード:IRTNTR13495
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2017年7月5日
◆ページ数:128
◆資料形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名利用)USD3,500 ⇒換算¥388,500見積依頼/購入/質問フォーム
Five User(~5名利用)USD4,000 ⇒換算¥444,000見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD5,000 ⇒換算¥555,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

当調査レポートでは、臓器移植用免疫抑制薬の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、臓器移植用免疫抑制薬の世界市場規模及び予測、薬剤種類別分析、市場の成長要因、市場の課題、市場動向、競争状況、主要企業(ベンダー)分析などの情報をお届けいたします。

About Organ Transplant ImmunosuppressantAn organ transplantation is a surgical procedure that involves replacing diseased organs such as a heart, liver, kidney, or lung with healthy organs. The donor organ can come from a deceased donor (who has recently passed away) such as in heart transplants, or kidney, liver, and rarely lung transplants from living donors. As per the Centers for Disease Control and Prevention (CDC) report, the most commonly transplanted organs in the US are the kidney, liver, heart, lungs, pancreas, and intestine. On any given day, there are about 75,000 people on active waiting list for organ transplantation. However, the organ donors are very few, leading to the high unmet need for organ availability. There are only 8,000 deceased organ donors annually, with each providing on average 3.5 organs. Living donors provide on average only around 6,000 organs per year.

Technavio’s analysts forecast the global organ transplant immunosuppressant market to grow at a CAGR of 3.81% during the period 2017-2021.

[Covered in this report]
The report covers the present scenario and the growth prospects of the global organ transplant immunosuppressant market for 2017-2021. To calculate the market size, the report considers the sales of both branded and generic drugs.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio’s report, Global Organ Transplant Immunosuppressant Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key vendors]
• Novartis,
• Astellas Pharma,
• Pfizer,
• Sanofi,

[Other prominent vendors]
• AbbVie
• Bristol-Myers Squibb
• F. Hoffmann-La Roche

[Market driver]
• Increased incidence of organ failure
• For a full, detailed list, view our report

[Market challenge]
• Insufficient organ supply
• For a full, detailed list, view our report

[Market trend]
• Growing trend of medical tourism
• For a full, detailed list, view our report

[Key questions answered in this report]
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

*** You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

【資料の目次】

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction
• Market outline

PART 05: Introduction to organ transplantation
• What is an organ transplantation?
• How common is organ transplantation?
• Increasing trend of organ transplantation
• Need for immunosuppression during organ transplant
• What is an immunosuppressant?
• Role of an immunosuppressant during organ transplant

PART 06: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis

PART 07: Key clinical trials

PART 08: Market segmentation by drug class
• Selective inhibitor of cytokine production and function
• Immunosuppressive antimetabolites
• Immunosuppressive antibodies
• Immunosuppressive adrenocorticosteroids

PART 09: Market segmentation by therapeutic application
• Kidney transplantation
• Liver transplantation
• Heart transplantation
• Lung transplantation
• Pancreas transplantation
• Other transplantation

PART 10: Geographical segmentation
• Organ transplant immunosuppressant market in Americas
• Organ transplant immunosuppressant market in EMEA
• Organ transplant immunosuppressant market in APAC

PART 11: Decision framework

PART 12: Drivers and challenges
• Market drivers
• Market challenges

PART 13: Market trends
• Growing trend of medical tourism
• New government initiatives on transplant research programs
• Growing focus toward the use of biologics

PART 14: Vendor landscape
• Competitive scenario

PART 15: Key vendor analysis
• Astellas Pharma
• Novartis
• Pfizer
• Sanofi
• Other prominent vendors

PART 16: Appendix
• List of abbreviations



【掲載企業】

Novartis, Astellas Pharma, Pfizer, Sanofi,AbbVie, Bristol-Myers Squibb, and F. Hoffmann-La Roche.

【資料のキーワード】

臓器移植、免疫抑制薬、免疫抑制剤

【調査方法】

一次資料による調査(業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など)及び二次資料による調査(Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど)

★調査レポート[臓器移植用免疫抑制薬の世界市場2017-2021] (Global organ transplant immunosuppressant market 2017-2021 / IRTNTR13495)販売に関する免責事項
[臓器移植用免疫抑制薬の世界市場2017-2021] (Global organ transplant immunosuppressant market 2017-2021 / IRTNTR13495)についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆